CAS 461023-63-2

Aplaviroc hydrochloride

CAS : 461023-63-2

Aplaviroc hydrochloride

Degré de pureté : 99%

Masse moléculaire : 614.18g/mol

Ref: 54-OR1066728

Aplaviroc hydrochloride

CAS : 461023-63-2

Aplaviroc is a small molecule that blocks the CCR5 receptor. It is used to treat HIV infection, as well as other diseases such as rheumatoid arthritis, chronic obstructive pulmonary disease, and others. Aplaviroc binds to the CCR5 receptor with high affinity and inhibits the binding of the natural ligand (CCL3) with high potency. The pharmacology of aplaviroc is related to its ability to block ion channels in a cell's membrane. This inhibition prevents the release of inflammatory molecules and slows down the progression of HIV infection by preventing viral entry into cells. Aplaviroc has been shown to be an effective inhibitor of HIV-1 replication in vitro and in vivo and has been approved for use in treating HIV-1 infection.
Aplaviroc hydrochloride is a small molecule that binds to the CCR5 receptor. It blocks inflammation by inhibiting ion channels that release inflammatory molecules from cells.

Formule : C₃₃H₄₄ClN₃O₆

Degré de pureté : Min. 95%

Masse moléculaire : 614.2 g/mol

Ref: 3D-LTA02363

Aplaviroc hydrochloride

CAS : 461023-63-2

Aplaviroc, a potent CCR5 inhibitor, binds selectively, blocking HIV entry and specific monoclonal antibody attachment in vitro.

Formule : C₃₃H₄₄ClN₃O₆

Couleur et forme : Solid

Masse moléculaire : 614.17

Ref: TM-T26642